About the Authors

Vijaya Ramachandran

Affiliation Department of Cancer Biology, University of Texas M. D. Anderson Cancer Centre, Houston, Texas, United States of America

Thiruvengadam Arumugam

Affiliation Department of Cancer Biology, University of Texas M. D. Anderson Cancer Centre, Houston, Texas, United States of America

Robert Langley

Affiliation Department of Cancer Biology, University of Texas M. D. Anderson Cancer Centre, Houston, Texas, United States of America

Rosa F. Hwang

Affiliation Department of Surgical Oncology, University of Texas M. D. Anderson Cancer Centre, Houston, Texas, United States of America

Pablo Vivas-Mejia

Affiliation Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Centre, Houston, Texas, United States of America

Anil K. Sood

Affiliations Department of Cancer Biology, University of Texas M. D. Anderson Cancer Centre, Houston, Texas, United States of America, Department of Gynecologic Oncology, University of Texas M. D. Anderson Cancer Centre, Houston, Texas, United States of America, Center for RNAi and Non-Coding RNA, University of Texas M. D. Anderson Cancer Centre, Houston, Texas, United States of America

Gabriel Lopez-Berestein

Affiliations Department of Cancer Biology, University of Texas M. D. Anderson Cancer Centre, Houston, Texas, United States of America, Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Centre, Houston, Texas, United States of America, Center for RNAi and Non-Coding RNA, University of Texas M. D. Anderson Cancer Centre, Houston, Texas, United States of America

Craig D. Logsdon

clogsdon@mdanderson.org

Affiliations Department of Cancer Biology, University of Texas M. D. Anderson Cancer Centre, Houston, Texas, United States of America, Department of Medical Oncology, University of Texas M. D. Anderson Cancer Centre, Houston, Texas, United States of America

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: VR TA RL RFH PEVM AS GLB CDL. Performed the experiments: VR TA. Analyzed the data: VR CDL. Contributed reagents/materials/analysis tools: RL RFH PEVM AS GLB. Wrote the paper: VR CDL.